Kuros Biosciences AG (CSBTF)
Kuros Biosciences AG is a healthcare company focused on biologic technologies for musculoskeletal care in the United States, the European Union, and other international markets. The company operates through two segments, Medical Devices and Legacy Portfolio. Its product range includes MagnetOs Granules, an advanced bone graft product using NeedleGrip surface technology, MagnetOs Putty for filling bony voids in spinal applications, and Attrax, a biphasic calcium phosphate bone graft designed to resemble the porous structure of cancellous bone. The company also has checkmate licensing activities. Kuros Biosciences was incorporated in 2016 and is headquartered in Schlieren, Switzerland. The listed security is common stock traded on OTC Markets under the symbol CSBT.F.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CSBT.F
|
$20.85
|
-18.5% Downside
|
Overvalued
|
—
|
—
|
—
|
Great
|
—
|
—
|
—
|
0.0%
|
August 13, 2026
|
385.2x
|
11.2x
|
6.5x
|
951.3 M
|
930.4 M
|
0.1%
|
73.9%
|
7.2
|
—
|
-117.5%
|
